Abpro Holdings, Inc

Industry

  • Biotechnology
    • Drug Discovery Technologies
      • Genomics-Proteomics
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing

Other Names/Subsidiaries

  • AbMed
  • Abpro-Labs
See more in Biomedtracker

Latest on Abpro Holdings, Inc

Scrip

Finance Watch: Adlai Nortye Raises $97.5m In IPO, Brings US Total To 18

 
• By Mandy Jackson

Several weeks after it first planned to go public in the US, China-based Adlai Nortye Ltd. launched its initial public offering on 29 September and a concurrent private placement that together gross

Scrip

Asia Deal Watch: Dong-A Brings In NeuroBo As Partner On Pair Of Cardiometabolic Candidates

 
• By Joseph Haas, Jung Won Shin, and Ian Haydock

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. NeuroBo Will Help Advance Dong-A Candid

Scrip

Asia Deal Watch: Athenex Changes Mind, Gets Back Chinese Rights To Actinic Keratosis Candidate

 
• By Ian Haydock, Anju Ghangurde, and Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions. Athenex Regains Chinese Rights

Scrip

Finance Watch: Six More IPO Filings As Three More Biopharmas Go Public In The US

 
• By Mandy Jackson

Three more biopharmaceuticals firms have gone public in the US – Kiniksa Pharmaceuticals Ltd. , Scholar Rock Holding Corp. and Iterum Therapeutics PLC – bringing the May total to six initial publ